NEO vs. HRI, HNGE, WSC, CARG, ATHM, RELY, PAGS, TNET, WNS, and YY
Should you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include Herc (HRI), Hinge Health (HNGE), WillScot (WSC), CarGurus (CARG), Autohome (ATHM), Remitly Global (RELY), PagSeguro Digital (PAGS), TriNet Group (TNET), WNS (WNS), and JOYY (YY). These companies are all part of the "business services" industry.
NeoGenomics vs. Its Competitors
NeoGenomics (NASDAQ:NEO) and Herc (NYSE:HRI) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.
98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 93.1% of Herc shares are owned by institutional investors. 2.4% of NeoGenomics shares are owned by company insiders. Comparatively, 1.3% of Herc shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Herc had 6 more articles in the media than NeoGenomics. MarketBeat recorded 9 mentions for Herc and 3 mentions for NeoGenomics. Herc's average media sentiment score of 0.67 beat NeoGenomics' score of 0.15 indicating that Herc is being referred to more favorably in the news media.
NeoGenomics currently has a consensus target price of $12.56, indicating a potential upside of 37.97%. Herc has a consensus target price of $149.20, indicating a potential upside of 18.01%. Given NeoGenomics' higher possible upside, analysts plainly believe NeoGenomics is more favorable than Herc.
NeoGenomics has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500. Comparatively, Herc has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500.
Herc has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Herc, indicating that it is currently the more affordable of the two stocks.
Herc has a net margin of 0.61% compared to NeoGenomics' net margin of -15.10%. Herc's return on equity of 20.77% beat NeoGenomics' return on equity.
Summary
Herc beats NeoGenomics on 12 of the 17 factors compared between the two stocks.
Get NeoGenomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeoGenomics Competitors List
Related Companies and Tools
This page (NASDAQ:NEO) was last updated on 10/6/2025 by MarketBeat.com Staff
